Skip navigation Return to standard layout with columns
Menu

VALMA: Voice, Activity, and Location Monitoring for Alzheimer’s Disease and Related Dementias

By Tung, James Y.; Semple, Jonathan F.L.; Woo, Wei Xian; Hsu, Wei-Shou; Sinn, Mathieu; Roy, Eric A.; Poupart, Pascal; RESNA/ICTA 2011: Advancing Rehabilitation Technologies for an Aging Society, June 5-8, 2011, Toronto, Canada,
Publication Date: 2011

Paper outlines the development of an ambulatory sensor system designed to capture natural behaviors across multiple domains to profile lifestyle risk factors related to Alzheimer’s disease (AD) and related dementias. Overall system design criteria were based on applicability to the elderly population at greatest risk for dementias and needed to be unobtrusive, sensitive, simple to use and control, and considerate to private data. The Voice, Activity, and Location Monitoring for Alzheimer’s Disease (VALMA) system has two main components: a smartphone and accelerometers placed on each ankle. The core of the system is an application run on a Nexus One smartphone, which itself runs Google’s Android mobile operating system. The phone contains a GPS receiver used to record location data. A wired headset is connected to the phone and audio data are recorded through the headset’s microphone. The ankle worn accelerometers operate independently of the phone and record data to their own internal memory, which is later retrieved via a USB connection. VALMA is used to monitor physical activity, sleeping patterns, social activity as reflected by mobility and verbal activity patterns, and dual tasking behaviors. Feasibility studies planned for VALMA will include a sample of community dwelling mild to moderate AD patients and healthy age-matched controls. Participants will undergo a battery of cognitive, language, and gait tests, followed by a 4 day everyday activity collection period. It is anticipated that assessment of everyday activity using VALMA will impact the design and prescription of exercise, sleep, and social interventions to prevent and slow disease progression.
Published by: Rehabilitation Engineering & Assistive Technology Society of North America (RESNA)   (Website:http://www.resna.org)

Rehabilitation Engineering & Assistive Technology Society of North America (RESNA)    (Web Site: http://www.resna.org )
Link to text: http://web.resna.org/conference/proceedings/2011/RESNA_ICTA/tung-69768.pdf

AbleData, 8630 Fenton Street, Suite 930, Silver Spring, MD 20910. 1-800-227-0216.
Maintained for the National Institute on Disability and Rehabilitation Research of the U.S. Dept. of Education
by ICF Macro under Contract No. ED-04-CO-0018/0007.

The records in AbleData are provided for information purposes only. Neither the U.S. Department of Education nor ICF Macro has examined, reviewed, or tested any product, device, or information contained in AbleData. The Department and ICF Macro make no endorsement, representation, or warranty express or implied as to any product, device, or information set forth in AbleData. The views expressed on this site do not necessarily represent the opinions of the Department of Education, the National Institute on Disability and Rehabilitation Research, or ICF Macro.